eNews
Home page > Comments


Comments

Watson seeks approval of generic version of cancer drug Velcade

29.12.2012. | (Reuters) - Watson Pharmaceuticals Inc said on Friday it has applied for U.S. approval to market a generic version of Velcade, a treatment for multiple myeloma made by Takeda Pharmaceutical Co....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: